Product Overview
Semaglutide Modified GLP-1 Analogue
High-quality Semaglutide for glp-1 receptor agonists and laboratory analytical research
Semaglutide is supplied as a modified glp-1 analogue for qualified laboratory research. It is intended for a modified glucagon-like peptide-1 analogue used in laboratory studies of GLP-1 receptor signalling, incretin biology, receptor binding and peptide analytical methods. Available specifications: 2 mg, 5 mg, 7 mg, 10 mg, 12 mg, 15 mg, 17 mg, 20 mg, 22 mg, 25 mg, 30 mg; 10 vials per box. For laboratory research use only. Not for human consumption, clinical use, diagnosis, treatment, compounding or veterinary use.
Synonym(s): Semaglutide; NN9535
Packaging & Availability
Pricing is supplied on request. Select one or more pack sizes to add them to your quote cart.
| Select | SKU | Pack Size | Availability | Price |
|---|---|---|---|---|
| SM2 | 2mg/vial | 10vial/box;M0Q:100boxes or 1000vial | On request | |
| SM5 | 5mg/vial | 10vial/box;M0Q:100boxes or 1000vial | On request | |
| SM7 | 7mg/vial | 10vial/box;M0Q:100boxes or 1000vial | On request | |
| SM10 | 10mg/vial | 10vial/box;M0Q:100boxes or 1000vial | On request | |
| SM12 | 12mg/vial | 10vial/box;M0Q:100boxes or 1000vial | On request | |
| SM15 | 15mg/vial | 10vial/box;M0Q:100boxes or 1000vial | On request | |
| SM17 | 17mg/vial | 10vial/box;M0Q:100boxes or 1000vial | On request | |
| SM20 | 20mg/vial | 10vial/box;M0Q:100boxes or 1000vial | On request | |
| SM22 | 22mg/vial | 10vial/box;M0Q:100boxes or 1000vial | On request | |
| SM25 | 25mg/vial | 10vial/box;M0Q:100boxes or 1000vial | On request | |
| SM30 | 30mg/vial | 10vial/box;M0Q:100boxes or 1000vial | On request |
Product Overview
Semaglutide is a modified glucagon-like peptide-1 analogue used in laboratory studies of GLP-1 receptor signalling, incretin biology, receptor binding and peptide analytical methods. The material is intended for qualified research organisations, analytical laboratories and product-development teams. It is supplied under batch-controlled conditions, and the final website specification must match the released COA.
Key Features
- Product type: Modified GLP-1 Analogue
- Available specifications: 2 mg, 5 mg, 7 mg, 10 mg, 12 mg, 15 mg, 17 mg, 20 mg, 22 mg, 25 mg, 30 mg; 10 vials per box
- Purity / grade: Research grade; enter the exact HPLC purity shown on the batch COA
- Appearance: White to off-white lyophilized powder; confirm against the batch COA
- Documentation: Batch COA; HPLC chromatogram; MS report; SDS and specification sheet where applicable
- Bulk supply and custom labelling are available subject to technical and compliance review
Research Applications
Typical non-clinical research use includes glp-1 receptor agonists, receptor or enzyme assays, peptide or small-molecule characterisation, chromatographic method development, mass-spectrometric confirmation, stability assessment and formulation compatibility studies. Researchers should determine suitability for their own protocol.
Supply & Quality Documentation
Batch-specific quality documentation is available according to the selected grade and order. Technical values shown on the website should be reconciled with the final COA, HPLC and MS results before release.
For laboratory research use only. Not for human consumption, clinical use, diagnosis, treatment, compounding or veterinary use.
Frequently Asked Questions
What is Semaglutide?
Semaglutide is a modified glucagon-like peptide-1 analogue used in laboratory studies of GLP-1 receptor signalling, incretin biology, receptor binding and peptide analytical methods. It is supplied solely for qualified laboratory research.
What specifications are available for Semaglutide?
Current catalogue specifications are 2 mg, 5 mg, 7 mg, 10 mg, 12 mg, 15 mg, 17 mg, 20 mg, 22 mg, 25 mg, 30 mg; 10 vials per box. Final availability must be confirmed when requesting a quotation.
What purity is supplied?
Research grade; enter the exact HPLC purity shown on the batch COA. The batch COA is the controlling quality record.
Which quality documents are available?
Batch COA; HPLC chromatogram; MS report; SDS and specification sheet where applicable. Document availability depends on the selected grade and batch.
How should Semaglutide be stored?
Store sealed at −20°C, protected from light and moisture. After reconstitution, follow the batch-specific stability instructions and avoid repeated freeze–thaw cycles.
Is Semaglutide intended for human use?
No. It is supplied for laboratory research only and is not intended for human consumption, clinical use, diagnosis, treatment, compounding or veterinary use.
Product Properties
| Product Name | Semaglutide |
|---|---|
| Product Type | Modified GLP-1 Analogue |
| Main Category | Metabolic Peptides |
| Subcategory | GLP-1 Receptor Agonists |
| Available Specifications | 2 mg, 5 mg, 7 mg, 10 mg, 12 mg, 15 mg, 17 mg, 20 mg, 22 mg, 25 mg, 30 mg; 10 vials per box |
| Purity / Grade | Research grade; enter the exact HPLC purity shown on the batch COA |
| Appearance | White to off-white lyophilized powder; confirm against the batch COA |
| Storage | Store sealed at −20°C, protected from light and moisture. After reconstitution, follow the batch-specific stability instructions and avoid repeated freeze–thaw cycles. |
| Quality Documents | Batch COA; HPLC chromatogram; MS report; SDS and specification sheet where applicable |
Analytical & Research Scope
Semaglutide may be used for a modified glucagon-like peptide-1 analogue used in laboratory studies of GLP-1 receptor signalling, incretin biology, receptor binding and peptide analytical methods. The purchaser is responsible for validating the material in the intended laboratory method.
Ordering Information
Please specify the required content, batch quantity, target purity, destination country, packaging format and required documents when requesting a quotation.
For laboratory research use only. Not for human consumption, clinical use, diagnosis, treatment, compounding or veterinary use.
- Read the batch-specific Safety Data Sheet before handling.
- Use suitable laboratory gloves, protective clothing and eye protection.
- Avoid inhalation, ingestion and direct contact with skin or eyes.
- Use only in a controlled laboratory environment with appropriate engineering controls.
- Store sealed at −20°C, protected from light and moisture. After reconstitution, follow the batch-specific stability instructions and avoid repeated freeze–thaw cycles.
- Dispose of unused material, containers and solutions in accordance with institutional and local regulations.
No clinical dosing, treatment or consumer-use information is provided.
Quality & Documentation
Safety Data Sheet (SDS), Certificate of Analysis (COA) and specification documents can be supplied with your quotation.